Butterfly Network Launches AI-Assisted Ultrasound Trial for Early Tuberculosis Detection in Sub-Saharan Africa
Reuters
Aug 19, 2025
Butterfly Network Launches AI-Assisted Ultrasound Trial for Early Tuberculosis Detection in Sub-Saharan Africa
Butterfly Network Inc., a digital health company known for its handheld, whole-body ultrasound technology, has announced its involvement in an international research study named CAD LUS4TB. The study will evaluate the impact of AI-assisted point-of-care ultrasound (POCUS) on tuberculosis (TB) triage in under-resourced settings, specifically targeting Sub-Saharan Africa. The trial, which is set to begin in September, will involve 3,000 adult patients and will be conducted by non-radiologist healthcare workers using AI-led POCUS to identify potential TB indicators. The aim is to facilitate TB detection without requiring extensive ultrasound training or laboratory testing. The results of the trial are yet to be presented. This initiative also aspires to establish evidence-driven policies that integrate AI-aided lung ultrasound into national healthcare systems. Powered by Butterfly's Ultrasound-on-Chip™ technology, the company aims to enhance diagnostic imaging access and reduce morbidity and mortality from TB in low- and middle-income countries.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Butterfly Network Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250819023960) on August 19, 2025, and is solely responsible for the information contained therein.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.